Global Biosimilars Market is estimated to reach $46.0 Billion by 2025, Says Variant Market Research
Bhavana Patel Seo Analyst help@variantmarketresearch.com Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
1
Biosimilars Market
Global Biosimilars market is estimated to reach $46.0 Billion by 2025; growing at a CAGR of 33% from 2017 to 2025. Biosimilars are the biotechnological product that is proved to be comparable to an already approved reference product in quality, non‐clinical and clinical evaluation. The generic equivalents of biologics are meant as a ‘biosimilars’. A biosimilar is a highly similar, comparable version of an approved biologic medicine, which undergo through clinical trials to demonstrate that it works just as the approved biologic medicine. It is used to treat a wide range of conditions including cancer and autoimmune diseases. Regulatory guidelines for biosimilar development and approval are rigorous and undergoing constant refinement. Biosimilars offer good alternate treatment options in patients who cannot be treated with synthetic DMARDs (Disease‐ modifying antirheumatic drugs).
Download Free Sample Copy of Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/bi osimilars-market/sample-request
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
2
Global Biosimilars Market Size and Forecast, 2016 - 2025
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
3
Biosimilars Market
Product, manufacturing type, disease and geography are the segment of biosimilars market. The product segment is categorized into recombinant non‐ glycosylated proteins (insulin, interferon, recombinant human growth hormone, and granulocyte colony‐stimulating factor), recombinant glycosylated proteins (erythropoietin, follitropin, and monoclonal antibodies), and recombinant peptides (glucagon, and calcitonin). In‐house manufacturing and contract manufacturing are the bifurcations of manufacturing type. Furthermore, oncology, chronic diseases, growth hormone deficiency, blood disorders, infectious diseases, autoimmune diseases, and other diseases are segregated under disease segment.
Browse the Complete Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/bi osimilars-market
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
4
Global Biosimilars Market, by Manufacturing Type
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
5
Top Key Players
Celltrion Inc.
Biocon
Hospira Inc.
Merck KGaA
Biogen
Genentech, Inc.
LG Life Sciences
Novartis AG
Synthon, and Teva Pharmaceutical Industries Ltd., among others.
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
6
Global Biosimilars Market Regional Revenue
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
7
The key takeaways from the report
The report will provide detailed analysis of Global Biosimilars Market with respect to major segments such as product, manufacturing type, disease and geography
The report will include the qualitative and quantitative analysis with market estimation over 2016 – 2025 and compound annual growth rate (CAGR) between 2017 and 2025
Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
An exhaustive regional analysis of Global Biosimilars Market has been included in the report
Profile of the key players in the Global Biosimilars Market will be provided, which include key financials, product & services, new developments and business strategies
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
8
Global Biosimilars Market Primary Interviews, by Geography
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
9
Scope of the Global Biosimilars Market Product Segments
Recombinant Non‐Glycosylated Proteins
Insulin
Interferon
Recombinant Human Growth Hormone
Granulocyte Colony‐Stimulating Factor
Recombinant Glycosylated Proteins
Erythropoietin
Follitropin
Monoclonal Antibodies
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
10
Scope of the Global Biosimilars Market Product Segments
Recombinant Peptides
Glucagon
Calcitonin
Manufacturing Type Segments
In‐House Manufacturing
Contract Manufacturing
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
11
Scope of the Global Biosimilars Market Disease Segments
Oncology
Chronic Diseases
Growth Hormone Deficiency
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Other Diseases
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
12
Scope of the Global Biosimilars Market Geographical Segments
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Rest of Europe
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
13
Scope of the Global Biosimilars Market Geographical Segments
Asia‐Pacific
India
China
Japan
South Korea
Rest of Asia‐Pacific
RoW
South America
Middle East
Africa
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
14
Table of Content Chapter 1 Prefix 1.1 Market Scope 1.2 Report Description 1.3 Research Methodology 1.3.1 Primary Research 1.3.2 Secondary Research 1.3.3 In‐house Data Modeling Chapter 2 Executive Summary 2.1 Global Biosimilars Market Year‐on‐Year Growth, 2017 – 2025 (%)
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
15
Table of Content Chapter 3 Market Outline 3.1 Market Inclination, Trend, Outlook and Viewpoint 3.2 Market Share Analysis: Company’s Competitive Scenario 3.3 Market Dynamics 3.3.1 Drivers 3.3.1.1 Impact Analysis 3.3.2 Restraints 3.3.2.1 Impact Analysis 3.3.3 Opportunities ..... Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
16
Table of Content Chapter 8 Company Profiles 8.1 Celltrion Inc. 8.2 Biocon 8.3 Merck KGaA 8.4 BIOGEN 8.5 Genentech, Inc. 8.6 LG LIFE SCIENCES 8.7 Novartis AG 8.8 Synthon 8.9 Teva Pharmaceutical Industries Ltd. 8.10 Hospira Inc. Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
17
Contact Us John Dave, Head ‐ Sales Variant Market Research 649 Mission St, 5th Floor, San Francisco, CA 94105, United States. Tel: +1‐415‐680‐2785 Fax: +1‐415‐680‐2786 Email: john.dave@variantmarketresearch.com Email: help@variantmarketresearch.com
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com
18
19
Thank-You‌..
Variant Market Research | help@variantmarketresearch.com | sales@variantmarketresearch.com